Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?
- 8 August 2008
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 137 (6) , 871-878
- https://doi.org/10.1017/s0950268808001076
Abstract
SUMMARY: Fourteen strains of S. Typhi (n=13) and S. Paratyphi A (n=1) resistant to ciprofloxacin were compared with 30 ciprofloxacin decreased-susceptibility strains on the basis of qnr plasmid analysis, and nucleotide substitutions at gyrA, gyrB, parC and parE. In ciprofloxacin-resistant strains, five S. Typhi and a single S. Paratyphi A showed triple mutations in gyrA (Ser83→Phe, Asp87→Asn, Glu133→Gly) and a novel mutation outside the quinolone resistance determining region (QRDR) (Met52→Leu). Novel mutations were also discovered in an isolate (minimum inhibitory concentration 8 μg/ml) in gyrA gene Asp76→Asn and outside the QRDR Leu44→Ile. Out of 30 isolates with reduced susceptibility, single mutation was found in 12 strains only. Genes encoding qnr plasmid (qnr A, qnr B, AAC1-F) were not detected in ciprofloxacin-resistant or decreased-susceptibility strains. Antimicrobial surveillance coupled with molecular analysis of fluoroquinolone resistance is warranted for reconfirming novel and established molecular patterns of resistance, which is quintessential for reappraisal of enteric fever therapeutics.Keywords
This publication has 23 references indexed in Scilit:
- Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in IndiaJournal of Medical Microbiology, 2007
- Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in IndiaJournal of Antimicrobial Chemotherapy, 2006
- Molecular Basis of Resistance Displayed by Highly Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in BangladeshJournal of Clinical Microbiology, 2006
- High-Level Resistance to Fluoroquinolones Linked to Mutations in gyrA , parC , and parE in Salmonella enterica Serovar Schwarzengrund Isolates from Humans in TaiwanAntimicrobial Agents and Chemotherapy, 2005
- Fluoroquinolone-resistantSalmonellaParatyphi AEmerging Infectious Diseases, 2005
- Prevalence of Mutations within the Quinolone Resistance-Determining Region of gyrA , gyrB , parC , and parE and Association with Antibiotic Resistance in Quinolone-Resistant Salmonella entericaAntimicrobial Agents and Chemotherapy, 2004
- Single-Nucleotide Polymorphism Mutation Spectra and Resistance to Quinolones in Salmonella enterica Serovar Enteritidis with a Mutator PhenotypeAntimicrobial Agents and Chemotherapy, 2004
- Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 2003
- Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, ChinaAntimicrobial Agents and Chemotherapy, 2003
- DNA Sequence Analysis of DNA Gyrase and DNA Topoisomerase IV Quinolone Resistance-Determining Regions of Salmonella enterica Serovar Typhi and Serovar Paratyphi AAntimicrobial Agents and Chemotherapy, 2002